For Black women living with estrogen receptor-positive (ER+) metastatic breast cancer, a new clinical trial offers hope in the quest to overcome treatment resistance and extend survival. The VIKTORIA-1 trial is evaluating a potentially groundbreaking drug called gedatolisib, nicknamed 'Get It All,' for its ability to inhibit the PI3K/AKT/mTOR pathway implicated in many cases of […]
